Melbourne: Australian scientists claim to have developed a simple and low-cost blood test that can determine how well cancer patients are responding to chemotherapy, which could help in adjusting its dosage on a case-to-case basis. According to Queensland Institute of Medical Research, the low-cost test discovered by a team at the institute can determine how well chemotherapy is working in patients suffering from Hodgkin`s lymphoma. The discovery by Maher Gandhi and Kimberley Jones from QIMR`s Clinical Immunohaematology Laboratory could mean personalised treatment for patients with blood cancer, reducing the amount of chemotherapy as needed on a case-to-case basis. "This has the potential to be a huge aid for doctors in their decision making and a faster and less invasive process for the patients," Gandhi said adding that "up until now, clinicians have relied on scans to help them judge how well people are responding to chemotherapy.
`Bee venom shots could kill backache`
Retinal implant partially restores sight in blinds